BSA and ABCB1 polymorphism affect the pharmacokinetics of sunitinib and its active metabolite in Asian mRCC patients receiving an attenuated sunitinib dosing regimen.
Cancer chemotherapy and pharmacology 2016 Aug .
Chae Jung-Woo, Teo Yi Ling, Ho Han Kiat, Lee Jaeyeon, Back Hyun-Moon, Yun Hwi-Yeol, Karlsson Mats O, Kwon Kwang-Il, Chan Alexand
Effect of the CYP3A5 and ABCB1 genotype on exposure, clinical response and manifestation of toxicities from sunitinib in Asian patients.
The pharmacogenomics journal 2015 Mar .
Teo Y L, Wee H L, Chue X P, Chau N M, Tan M-H, Kanesvaran R, Wee H L, Ho H K, Chan